ciprofloxacin has been researched along with Meningococcal Infections in 63 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Meningococcal Infections: Infections with bacteria of the species NEISSERIA MENINGITIDIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Meningococcal disease is a contagious bacterial infection caused by Neisseria meningitidis (N." | 2.49 | Antibiotics for preventing meningococcal infections. ( Fraser, A; Gafter-Gvili, A; Leibovici, L; Paul, M; Zalmanovici Trestioreanu, A, 2013) |
| "Meningococcal disease is a contagious bacterial infection caused by Neisseria meningitidis (N." | 2.47 | Antibiotics for preventing meningococcal infections. ( Fraser, A; Gafter-Gvili, A; Leibovici, L; Paul, M; Zalmanovici Trestioreanu, A, 2011) |
| "Meningococcal disease is a contagious bacterial disease caused by Neisseria meningitidis (N." | 2.43 | Antibiotics for preventing meningococcal infections. ( Fraser, A; Gafter-Gvili, A; Leibovici, L; Paul, M, 2005) |
| "Meningococcal disease is a contagious bacterial disease caused by Neisseria meningitidis (N." | 2.43 | Antibiotics for preventing meningococcal infections. ( Fraser, A; Gafter-Gvili, A; Leibovici, L; Paul, M, 2006) |
| "Chemoprophylaxis of meningococcal disease is still necessary in spite of the availability of an effective vaccine against group A, C, Y and W135 strain meningococci." | 2.38 | Ciprofloxacin in meningococcal carriers. ( Visakorpi, R, 1989) |
| "Ciprofloxacin resistance was attributed to an amino acid substitution in DNA gyrase (T91I)." | 1.62 | Emergence of MDR invasive Neisseria meningitidis in El Salvador, 2017-19. ( Barrientos, AM; Camargo, CH; Cunha, MPV; Gabastou, JM; Galas, M; Lemos, APS; Luna, MJ; Marín, JEO; Mendoza, E; Sacchi, CT; Villatoro, E, 2021) |
| "Ciprofloxacin was safe and effective, with no serious or persistent osteoarticular effects in children." | 1.31 | [Control of a school outbreak of serogroup B meningococcal disease by chemoprophylaxis with azithromycin and ciprofloxacin]. ( García Merino, J; González de Aledo Linos, A, 2000) |
| "Invasive meningococcal disease is a significant cause of mortality and morbidity in the UK." | 1.31 | Variations in chemoprophylaxis for meningococcal disease: a retrospective case note review, analysis of routine prescribing data and questionnaire of general practitioners. ( Marks, PJ; Neal, KR, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (6.35) | 18.7374 |
| 1990's | 7 (11.11) | 18.2507 |
| 2000's | 20 (31.75) | 29.6817 |
| 2010's | 20 (31.75) | 24.3611 |
| 2020's | 12 (19.05) | 2.80 |
| Authors | Studies |
|---|---|
| Enríquez, R | 2 |
| Abad, R | 2 |
| Salcedo, C | 1 |
| Vázquez, JA | 3 |
| Potts, CC | 2 |
| Rodriguez-Rivera, LD | 1 |
| Retchless, AC | 3 |
| Hu, F | 2 |
| Marjuki, H | 1 |
| Blain, AE | 2 |
| McNamara, LA | 4 |
| Wang, X | 4 |
| Saito, R | 2 |
| Nakajima, J | 1 |
| Prah, I | 1 |
| Morita, M | 2 |
| Mahazu, S | 1 |
| Ota, Y | 2 |
| Kobayashi, A | 1 |
| Tohda, S | 1 |
| Kamiya, H | 1 |
| Takahashi, H | 3 |
| Ohnishi, M | 2 |
| Okada, R | 1 |
| Rude, JM | 1 |
| Kortimai, L | 1 |
| Mosoka, F | 1 |
| April, B | 1 |
| Nuha, M | 1 |
| Katawera, V | 1 |
| Nagbe, T | 1 |
| Tamba, A | 1 |
| Desmound, W | 1 |
| Mulbah, R | 1 |
| Pierre, F | 1 |
| Onuche, EM | 1 |
| Chukwudi, JO | 1 |
| Talisuna, A | 1 |
| Yahaya, AA | 1 |
| Rajatonirina, S | 1 |
| Nyenswah, T | 1 |
| Dahn, B | 1 |
| Gasasira, A | 1 |
| Fall, IS | 1 |
| Lahra, MM | 3 |
| Enriquez, RP | 2 |
| Hogan, TP | 1 |
| Tzanakaki, G | 1 |
| Georgakopoulou, T | 1 |
| Xirogianni, A | 1 |
| Papandreou, A | 1 |
| Deghmane, AE | 2 |
| Magaziotou, I | 1 |
| Taha, MK | 6 |
| Taormina, G | 1 |
| Campos, J | 1 |
| Sweitzer, J | 1 |
| Lunquest, K | 1 |
| Reese, N | 2 |
| Karlsson, M | 2 |
| Hanisch, B | 1 |
| Hogan, TR | 1 |
| Willerton, L | 1 |
| Lucidarme, J | 1 |
| Campbell, H | 1 |
| Caugant, DA | 1 |
| Claus, H | 1 |
| Jacobsson, S | 1 |
| Ladhani, SN | 1 |
| Mölling, P | 1 |
| Neri, A | 2 |
| Stefanelli, P | 3 |
| Vogel, U | 1 |
| Borrow, R | 1 |
| Juscamayta-López, E | 1 |
| Valdivia, F | 1 |
| Morales, S | 1 |
| Donaires, LF | 1 |
| Fiestas-Solórzano, V | 1 |
| Oré, M | 1 |
| Pachas, P | 1 |
| León-Janampa, N | 1 |
| Gavilán, R | 1 |
| Bennett, DE | 1 |
| Meyler, KL | 1 |
| Cafferkey, MT | 1 |
| Cunney, RJ | 1 |
| Marín, JEO | 1 |
| Villatoro, E | 1 |
| Luna, MJ | 1 |
| Barrientos, AM | 1 |
| Mendoza, E | 1 |
| Lemos, APS | 1 |
| Camargo, CH | 1 |
| Sacchi, CT | 1 |
| Cunha, MPV | 1 |
| Galas, M | 1 |
| Gabastou, JM | 1 |
| Marasini, D | 1 |
| Swint, S | 1 |
| Sharma, S | 1 |
| Lonsway, D | 1 |
| Hariri, S | 1 |
| Fox, LM | 1 |
| Kawasaki, Y | 1 |
| Matsubara, K | 1 |
| Hori, M | 1 |
| Isome, K | 1 |
| Iwata, A | 1 |
| Nigami, H | 1 |
| Ikemachi, M | 1 |
| Yamamoto, G | 1 |
| Ohkusu, K | 1 |
| Gorla, MC | 2 |
| Cassiolato, AP | 1 |
| Pinhata, JMW | 2 |
| de Moraes, C | 2 |
| Corso, A | 1 |
| Gagetti, P | 1 |
| Lemos, AP | 2 |
| Lee, H | 1 |
| Seo, Y | 1 |
| Kim, KH | 1 |
| Lee, K | 1 |
| Choe, KW | 1 |
| Dias, UJ | 1 |
| Vacca, P | 1 |
| Vocale, C | 1 |
| Fazio, C | 2 |
| Ambrosio, L | 1 |
| Luzi, K | 1 |
| Palmieri, A | 1 |
| Zalmanovici Trestioreanu, A | 2 |
| Fraser, A | 4 |
| Gafter-Gvili, A | 4 |
| Paul, M | 4 |
| Leibovici, L | 4 |
| Zhu, B | 1 |
| Fan, Y | 1 |
| Xu, Z | 1 |
| Xu, L | 1 |
| Du, P | 1 |
| Gao, Y | 1 |
| Shao, Z | 1 |
| O'Connor, L | 1 |
| Ward, M | 1 |
| Bennett, D | 1 |
| Mulhall, R | 1 |
| O'Lorcain, P | 1 |
| Cunney, R | 1 |
| McDermott, R | 1 |
| Neville, E | 1 |
| Heslin, J | 1 |
| FitzGerald, R | 1 |
| Meyler, K | 1 |
| Conlon, M | 1 |
| Clarke, A | 1 |
| Corcoran, B | 1 |
| Fitzpatrick, G | 1 |
| O'Connor, B | 1 |
| Flanagan, P | 1 |
| O'Flanagan, D | 1 |
| Cotter, S | 1 |
| Soeters, HM | 1 |
| Whaley, M | 1 |
| Alexander-Scott, N | 1 |
| Kanadanian, KV | 1 |
| Kelleher, CM | 1 |
| MacNeil, J | 1 |
| Martin, SW | 1 |
| Raines, N | 1 |
| Sears, S | 1 |
| Vanner, C | 1 |
| Vuong, J | 1 |
| Bandy, U | 1 |
| Sicard, K | 1 |
| Patel, M | 1 |
| Arakawa, R | 1 |
| Mori, N | 1 |
| Kagawa, N | 1 |
| Higuchi, A | 1 |
| Tanaka, M | 1 |
| Aoki, Y | 1 |
| Seki, S | 1 |
| Suzuki, R | 1 |
| Rasoanandrasana, S | 1 |
| Raberahona, M | 1 |
| Milenkov, M | 1 |
| Rakotomahefa Narison, ML | 1 |
| Ranaivo Rabetokotany, F | 1 |
| Rakotovao, L | 1 |
| Randria, MJD | 1 |
| Hong, E | 2 |
| Paranhos-Baccalà, G | 1 |
| Rakoto-Andrianarivelo, M | 1 |
| Tsang, RS | 1 |
| Law, DK | 1 |
| Deng, S | 1 |
| Hoang, L | 1 |
| Friedl, C | 1 |
| Hackl, G | 1 |
| Schilcher, G | 1 |
| Rosenkranz, AR | 1 |
| Eller, K | 1 |
| Eller, P | 1 |
| Skoczynska, A | 1 |
| Alonso, JM | 1 |
| Strahilevitz, J | 1 |
| Adler, A | 1 |
| Smollan, G | 1 |
| Temper, V | 1 |
| Keller, N | 2 |
| Block, C | 2 |
| Wu, HM | 1 |
| Harcourt, BH | 1 |
| Hatcher, CP | 1 |
| Wei, SC | 1 |
| Novak, RT | 1 |
| Juni, BA | 1 |
| Glennen, A | 1 |
| Boxrud, DJ | 1 |
| Rainbow, J | 1 |
| Schmink, S | 1 |
| Mair, RD | 1 |
| Theodore, MJ | 1 |
| Sander, MA | 1 |
| Miller, TK | 1 |
| Kruger, K | 1 |
| Cohn, AC | 1 |
| Clark, TA | 1 |
| Messonnier, NE | 1 |
| Mayer, LW | 1 |
| Lynfield, R | 1 |
| Giovanetti, F | 1 |
| Ngo, VP | 1 |
| Civen, RH | 1 |
| Dassey, DE | 1 |
| Davenport, D | 1 |
| Mascola, L | 1 |
| Husain, EH | 1 |
| Dashti, AA | 1 |
| Electricwala, QY | 1 |
| Abdulsamad, AM | 1 |
| Al-Sayegh, S | 1 |
| Thulin Hedberg, S | 1 |
| Jolley, KA | 1 |
| Unemo, M | 1 |
| Veyrier, FJ | 1 |
| Jiang, JJ | 1 |
| Zhang, S | 1 |
| Angeles, J | 1 |
| Faye, A | 1 |
| Mariani-Kurkjian, P | 1 |
| Louzeau, C | 1 |
| Bingen, E | 1 |
| Bourrillon, A | 1 |
| Gupta, P | 1 |
| Choudhury, P | 1 |
| Allan, RC | 1 |
| Moghal, M | 1 |
| Wijesuriya, V | 1 |
| Melzer, M | 1 |
| Gardner, P | 1 |
| Singhal, S | 1 |
| Purnapatre, KP | 1 |
| Kalia, V | 1 |
| Dube, S | 1 |
| Nair, D | 1 |
| Deb, M | 1 |
| Aggarwal, P | 1 |
| Gupta, S | 1 |
| Upadhyay, DJ | 1 |
| Rattan, A | 1 |
| Raj, VS | 1 |
| Blondeau, JM | 1 |
| Yaschuk, Y | 1 |
| Martin, MJ | 1 |
| Hutchinson, NA | 1 |
| Eltringham, IJ | 1 |
| Lee, PY | 1 |
| Birthistle, K | 1 |
| Shehab, S | 1 |
| Barkay, A | 1 |
| Leitner, L | 1 |
| Leventhal, A | 1 |
| Arreaza, L | 1 |
| de la Fuente, L | 1 |
| Fernández, S | 1 |
| Rodríguez Núñez, A | 1 |
| Martinón Torres, F | 1 |
| Martinón Sánchez, J | 1 |
| Ortiz-Santamaria, V | 1 |
| Giménez, M | 1 |
| Casado, E | 1 |
| Olivé, A | 1 |
| González de Aledo Linos, A | 1 |
| García Merino, J | 1 |
| Carabias, ML | 1 |
| Cervera, LA | 1 |
| García-Navas, BL | 1 |
| entelles, ML | 1 |
| Marks, PJ | 1 |
| Neal, KR | 1 |
| Sharma, M | 1 |
| Naqvi, A | 1 |
| Maollod, L | 1 |
| Khatib, R | 1 |
| Maher, D | 1 |
| Visakorpi, R | 1 |
| Gaunt, PN | 2 |
| Wall, RA | 1 |
| Lambert, BE | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Establishing and Evaluating a School and University Campus-Based Approach to Implementing Serogroup B Meningococcal (MenB) Disease Recommendations in Older Adolescents and Young Adults.[NCT02975596] | 1,326 participants (Actual) | Interventional | 2016-12-31 | Completed | |||
| A Randomized Observer-blinded Controlled Non-inferiority Trial to Evaluate the Immunogenicity of Locally Manufactured Meningococcal ACWY Vaccine 'Ingovax ACWY' in Bangladeshi Healthy Adults.[NCT03263403] | Phase 2/Phase 3 | 88 participants (Actual) | Interventional | 2017-08-21 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
9 reviews available for ciprofloxacin and Meningococcal Infections
| Article | Year |
|---|---|
Antibiotics for preventing meningococcal infections.
Topics: Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Humans; Meningococcal Infections; Min | 2013 |
Waterhouse-Friderichsen syndrome due to Neisseria meningitidis infection in a young adult with thrombotic microangiopathy and eculizumab treatment: case report and review of management.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Ciprofloxacin; | 2017 |
Antibiotics for preventing meningococcal infections.
Topics: Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Humans; Meningococcal Infections; Min | 2011 |
Antibiotics for preventing meningococcal infections.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Humans; Meningococcal Infections; Minocycline; Nei | 2005 |
Clinical practice. Prevention of meningococcal disease.
Topics: Adolescent; Adult; Anti-Infective Agents; Ceftriaxone; Child; Ciprofloxacin; Disease Outbreaks; Huma | 2006 |
Antibiotics for preventing meningococcal infections.
Topics: Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Humans; Meningococcal Infections; Min | 2006 |
Guidelines for control of meningococcal disease. Laboratory Centre for Disease Control. Canadian Consensus Conference on Meningococcal Disease.
Topics: Adolescent; Adult; Bacterial Vaccines; Canada; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; | 1994 |
Ciprofloxacin in meningococcal carriers.
Topics: Carrier State; Ciprofloxacin; Drug Evaluation; Humans; Meningococcal Infections | 1989 |
The chemoprophylaxis of meningococcal infection.
Topics: Anti-Bacterial Agents; Carrier State; Ceftriaxone; Ciprofloxacin; Half-Life; Humans; Meningococcal I | 1988 |
54 other studies available for ciprofloxacin and Meningococcal Infections
| Article | Year |
|---|---|
Nalidixic acid disk for laboratory detection of ciprofloxacin resistance in Neisseria meningitidis.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Meningococcal Infections; | 2009 |
Antimicrobial Susceptibility Survey of Invasive Neisseria meningitidis, United States 2012-2016.
Topics: Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Humans; Meningococcal Infections; Mic | 2022 |
Penicillin- and Ciprofloxacin-Resistant Invasive Neisseria meningitidis Isolates from Japan.
Topics: Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Humans; Japan; Meningococcal Infections; Microbia | 2022 |
A mismatch amplification mutation assay for specific detection of ciprofloxacin-resistant Neisseria meningitidis.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Meningococcal Infections; | 2023 |
Rapid response to meningococcal disease cluster in Foya district, Lofa County, Liberia January to February 2018.
Topics: Adolescent; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Diseas | 2019 |
Australian Meningococcal Surveillance Programme annual report, 2018.
Topics: Adult; Age Distribution; Anti-Bacterial Agents; Australia; Ceftriaxone; Child; Child, Preschool; Cip | 2020 |
First report of meningococcal ciprofloxacin resistance in Greece due to invasive isolates of the sequence type ST-3129.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Bacteria | 2020 |
β-Lactamase-Producing, Ciprofloxacin-Resistant Neisseria meningitidis Isolated From a 5-Month-Old Boy in the United States.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Humans; Infant; Male; Meningococcal Infections; Microbial Sens | 2021 |
Australian Meningococcal Surveillance Programme annual report, 2019.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Australia; Ceftriaxone; Child; Child, Preschool; Cip | 2020 |
Geographically widespread invasive meningococcal disease caused by a ciprofloxacin resistant non-groupable strain of the ST-175 clonal complex.
Topics: Ciprofloxacin; England; Europe; Germany; Humans; Italy; Meningococcal Infections; Neisseria meningit | 2020 |
Emergence of ciprofloxacin-resistant
Topics: Anti-Bacterial Agents; Carrier State; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Meningococc | 2021 |
Antibiotic susceptibility and molecular analysis of invasive Neisseria meningitidis recovered in the Republic of Ireland, 1996 to 2016.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Genotype; Humans; Ireland; Meningococcal I | 2021 |
Emergence of MDR invasive Neisseria meningitidis in El Salvador, 2017-19.
Topics: Anti-Bacterial Agents; Ciprofloxacin; El Salvador; Humans; Meningococcal Infections; Neisseria menin | 2021 |
Acquisition of Ciprofloxacin Resistance Among an Expanding Clade of β-Lactamase-Positive, Serogroup Y Neisseria meningitidis in the United States.
Topics: Anti-Bacterial Agents; beta-Lactamases; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Meningoco | 2021 |
Invasive meningococcal disease due to ciprofloxacin-resistant Neisseria meningitidis sequence type 4821: The first case in Japan.
Topics: Anti-Bacterial Agents; Ceftriaxone; Child, Preschool; Ciprofloxacin; Diagnostic Tests, Routine; Drug | 2018 |
Emergence of resistance to ciprofloxacin in Neisseria meningitidis in Brazil.
Topics: Anti-Bacterial Agents; Brazil; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bac | 2018 |
Prevalence and serogroup changes of Neisseria meningitidis in South Korea, 2010-2016.
Topics: Adolescent; Adult; Aged; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Bacte | 2018 |
Surveillance of antimicrobial resistance in Neisseria meningitidis strains isolated from invasive cases in Brazil from 2009 to 2016.
Topics: Adolescent; Ampicillin; Anti-Infective Agents; Brazil; Ceftriaxone; Child; Child, Preschool; Chloram | 2018 |
Invasive meningococcal disease due to ciprofloxacin-resistant Neisseria meningitidis Sequence Type 7926: the first case in Italy, likely imported.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Communicable Diseases, Imported; Drug Resistance, Bacterial; H | 2019 |
Genetic diversity and clonal characteristics of ciprofloxacin-resistant meningococcal strains in China.
Topics: Anti-Bacterial Agents; China; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Gene Expression | 2014 |
Australian Meningococcal Surveillance Programme annual report, 2013.
Topics: Adolescent; Adult; Age Distribution; Aged; Annual Reports as Topic; Anti-Bacterial Agents; Australia | 2014 |
A prolonged outbreak of invasive meningococcal disease in an extended Irish Traveller family across three Health Service Executive (HSE) areas in Ireland, 2010 to 2013.
Topics: Adolescent; Adult; Catchment Area, Health; Chemoprevention; Child; Child, Preschool; Ciprofloxacin; | 2015 |
Serogroup B Meningococcal Disease Outbreak and Carriage Evaluation at a College - Rhode Island, 2015.
Topics: Adolescent; Anti-Bacterial Agents; Carrier State; Ciprofloxacin; Disease Outbreaks; Female; Humans; | 2015 |
[Meningococcal Septicemia Revealing Multiple Myeloma: A Case Report].
Topics: Ciprofloxacin; Disseminated Intravascular Coagulation; Humans; Male; Meningococcal Infections; Middl | 2016 |
Resurgence of Neisseria meningitidis serogroup W ST-11 (cc11) in Madagascar, 2015-2016.
Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Typing Techniques; Cephalosporins; C | 2017 |
Ciprofloxacin-resistant Neisseria meningitidis in Canada: likely imported strains.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Canada; China; Ciprofloxacin; Disease Outbreaks; Dru | 2017 |
Ciprofloxacin resistance in Neisseria meningitidis, France.
Topics: Ciprofloxacin; Drug Resistance, Bacterial; France; Humans; Meningococcal Infections; Neisseria menin | 2008 |
Serogroup A Neisseria meningitidis with reduced susceptibility to ciprofloxacin.
Topics: Anti-Bacterial Agents; Base Sequence; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Bacterial; Gen | 2008 |
Emergence of ciprofloxacin-resistant Neisseria meningitidis in North America.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Base Sequence; Carrier State; Ciprofloxacin; Drug Re | 2009 |
Anaphylaxis following unnecessary meningococcal chemoprophylaxis of a healthcare worker.
Topics: Adult; Anaphylaxis; Anti-Infective Agents; Ciprofloxacin; Female; Health Personnel; Humans; Infectio | 2009 |
Using a point-of-dispensing clinic for prophylaxis of meningococcal disease.
Topics: Adolescent; Anti-Infective Agents; Antibiotic Prophylaxis; Ciprofloxacin; Female; Health Care Survey | 2010 |
Absence of Neisseria meningitidis from throat swabs of Kuwaiti pilgrims after returning from the Hajj.
Topics: Adult; Anti-Infective Agents; Antibiotic Prophylaxis; Carrier State; Ciprofloxacin; Disease Outbreak | 2010 |
Target gene sequencing to define the susceptibility of Neisseria meningitidis to ciprofloxacin.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; DNA Gyrase; Female; Meningococ | 2013 |
Primary meningococcal arthritis requiring surgical drainage.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Arthritis, Infectious; Ceftriaxone; Ciprofloxac | 2013 |
[Clinical aspects and outcome of meningococcal disease due to Neisseria meningitidis of serogroup W135 in 5 children].
Topics: Anti-Bacterial Agents; Arthritis, Infectious; Cefotaxime; Child; Child, Preschool; Ciprofloxacin; Fe | 2005 |
Meningococcemia update vaccination and chemoprophylaxis.
Topics: Anti-Infective Agents; Ciprofloxacin; Humans; India; Meningococcal Infections; Meningococcal Vaccine | 2005 |
University-acquired pneumonia.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Cefuroxime; Ciprofloxacin; Community-Acquired Infections; | 2006 |
Ciprofloxacin-resistant Neisseria meningitidis, Delhi, India.
Topics: Ciprofloxacin; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Humans; India; Meningococcal | 2007 |
In brief: Meningococcal prophylaxis.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Meningo | 2008 |
In vitro activities of ciprofloxacin, cefotaxime, ceftriaxone, chloramphenicol, and rifampin against fully susceptible and moderately penicillin-resistant Neisseria meningitidis.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Canada; Cefotaxime; Ceftriaxone; Cephalosporins; Chlor | 1995 |
Secondary prevention of meningococcal disease. Ceftriaxone or ciprofloxacin should be considered as first line prophylaxis.
Topics: Ceftriaxone; Ciprofloxacin; Humans; Meningitis, Meningococcal; Meningococcal Infections | 1996 |
Control and prevention of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Topics: Adolescent; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Vaccines; Ceftriaxone; Child; C | 1997 |
Failure of mass antibiotic prophylaxis to control a prolonged outbreak of meningococcal disease in an Israeli village.
Topics: Adolescent; Adult; Age Distribution; Anti-Infective Agents; Antibiotic Prophylaxis; Carrier State; C | 1998 |
Allergic reactions to ciprofloxacin chemoprophylaxis.
Topics: Anti-Infective Agents; Chemoprevention; Ciprofloxacin; Disease Outbreaks; Drug Hypersensitivity; Hum | 1999 |
[Susceptibility to antimicrobial drugs used in the prophylaxis of meningococcal disease: situation after an epidemic wave].
Topics: Adolescent; Adult; Bacterial Vaccines; Carrier State; Ceftriaxone; Child; Child, Preschool; Ciproflo | 2000 |
[Chemoprophylaxis of meningococcal disease with azithromycin and ciprofloxacin].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Child; Ciprofloxacin; Humans; Meningococ | 2001 |
Primary meningococcal arthritis in the elderly.
Topics: Administration, Oral; Aged; Anti-Infective Agents; Arthritis, Infectious; Cefuroxime; Cephalosporins | 2001 |
[Control of a school outbreak of serogroup B meningococcal disease by chemoprophylaxis with azithromycin and ciprofloxacin].
Topics: Adolescent; Adult; Age Factors; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Child; C | 2000 |
[Are the antimicrobials used in community-acquired respiratory infection useful for preventing transmission of meningococcal disease? In vitro study].
Topics: Amoxicillin; Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Community-Acquired Infections; Dr | 2001 |
Variations in chemoprophylaxis for meningococcal disease: a retrospective case note review, analysis of routine prescribing data and questionnaire of general practitioners.
Topics: Anti-Infective Agents; Antibiotic Prophylaxis; Antibiotics, Antitubercular; Ciprofloxacin; Contact T | 2001 |
Meningococcemia following tonsillectomy.
Topics: Adult; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Humans; Male; Meningococcal Infections; Po | 2001 |
A problem with oral rifampicin in the prophylaxis of meningococcal infection.
Topics: Administration, Oral; Ciprofloxacin; Humans; Infant; Male; Meningococcal Infections; Penicillins; Ri | 1991 |
Ciprofloxacin vs ceftriaxone for eradication of meningococcal carriage.
Topics: Carrier State; Ceftriaxone; Ciprofloxacin; Humans; Meningococcal Infections | 1988 |
Single dose ciprofloxacin for the eradication of pharyngeal carriage of Neisseria meningitidis.
Topics: Carrier State; Ciprofloxacin; Half-Life; Humans; Meningitis, Meningococcal; Meningococcal Infections | 1988 |